Caffeic acid ester fraction from erigeron breviscapus inhibits microglial activation and provides neuroprotection

Chinese Journal of Integrative Medicine

Volumn 18, Issue 6, 2012, Pages 437-444

  Wang, Shao Xia ^a   Guo, Hong ^a   Hu, Li Min ^a   Liu, Ya Nan ^a   Wang, Yue Fei ^a   Kang, Li Yuan ^a   Gao, Xiu Mei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Dicaffeoylquinic acid; Inflammation; Microglia; Neuroprotcetion

Indexed keywords

CAFFEIC ACID; CAFFEIC ACID ESTER FRACTION; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; IN VITRO STUDY; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CAFFEIC ACIDS; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERIGERON; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-1BETA; MICROGLIA; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; QUINIC ACID; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867326234     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1114-y     Document Type: Article

References (36)

1. Oechmichen M, Meissner C. Cerebral hypoxia and ischemia: the forensic point of view: a review. J Forensic Sci 2006;51:880-887.
2. Lee JM, Grabb MC, Zipfel GJ, Choi DW. Brain tissue responses to ischemia. J Clin Invest 2000;106:723-731.
3. Zheng Z, Zhao H, Steinberg GK, Yenari MA. Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News Perspect 2003;16:497-503.
4. Neumann H, Kotter MR, Franklin RJM. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009;132:288-295.
5. Kaushal V, Schlichter LC. Mechanisms of microgliamediated neurotoxicity in a new model of the stroke penumbra. J Neurosci 2008;28:2221-2230.
6. Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Berg GI, et al. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007;38:646-651.
7. The Pharmacopoeia Commission of PRC. Pharmacopoeia of the People's Republic of China version 2005. Vol. 1, Beijing: Beijing Chemical Industry Press, 2005:184-185.
8. Wang JL, Gu W, Tan F. Effect of erigeron injection on platelet level of CD62p and serum content of TNF-alpha and IL-6 in patients with acute cerebral infarction. Chin J Integr Tradit West Med (Chin) 2005;25:324-326.
9. Huang PP, Han ZC, Li SZ, Liu C. Sixty-four patients with ischemic diseases of lower limbs treated by combined therapy of Erigeron breviscapus injection and heparin. Chin J Integr Tradit West Med (Chin) 2004;24:1016-1017.
10. Jiang B, Jiang YQ. The neuroprotective effect of erigeron breviscapus (vant) hand-mazz on retinal ganglion cells after optic nerve crush injury. Chin J Ophthalm (Chin) 2003;39:481-484.
11. Shi J, Jiag Y, Liu X. Neuroprotective effect of erigeron breviscapus (vant) hand-mazz on NMDA-induced retinal neuron injury in the rats. Eye Sci (Chin) 2004;20:113-117.
12. Tao YH, Jiang DY, Xu HB, Yang XL. Inhibitory effect of Erigeron breviscapus extract and its flavonoid components on GABA shunt enzymes. Phytomedicine 2008;15:92-97.
13. Wang M, Xie C, Cai RL, Li XH, Luo XZ, Qi Y. Studies on antioxidant activities of breviscapine in the cell-free system. Am J Chin Med 2008;36:1199-1207.
14. Liu H, Yang X, Ren T, Feng Y, Xu H. Effects of Erigeron breviscapus ethanol extract on neuronal oxidative injury induced by superoxide radical. Fitoterapia 2005;76:666-670.
15. Wang Y, Yang X, Liu H, Tang X. Study on effects of Erigeron breviscapus extract on anticoagulation. J Chin Med Mater (Chin) 2003;26:656-658.
16. Zhang Z, Luo P, Li J, Yi T, Wang J, An J, et al. Comparison of the antiinflammatory activities of three medicinal plants known as "meiduoluomi" in Tibetan folk medicine. Yakugaku Zasshi 2008;128:805-810.
17. Yang SC, Zhang XF, Zhang LM, Liu LX, Yang YJ, et al. Study on optimal harvest time of Erigeron breviscapus. Chin J Chin Mater Med (Chin) 2008;33:2744-2746.
18. Zhang WD, Ha TB, Chen WS, Kong DY, Li HT, Wang YH, et al. Study on the structure and activity of new phenolic acid compounds from Erigeron breviscapus. Acta pharm Sin (Chin) 2001;360-363.
19. Liuzzi GM, Mastroianni CM, Latronico T, Mengoni F, Fasano A, Lichtner M, et al. Anti-HIV drugs decrease the expression of matrixmetalloproteinases in astrocytes and microglia. Brain 2004;127:398-407.
20. Antonelli T, Tomasini M, Fournier J, Mazza R, Tanganelli S, Pirondi S, et al. Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation. Cereb Cortex 2008;18:1748-1757.
21. Lu VB, Biggs JE, Stebbing MJ, Balasubramanyan S, Todd KG, Lai AY, et al. Brain-derived neurotrophic factor drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury. J Physiol 2009;587:1013-1032.
22. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Handingham SJ,et al. Functional assessments in mice and rats after focal stroke. Neuropharmacology 2000;39:806-816.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 2001;25:402-408.
24. Yrjänheikki J, Keinänen R, Pellikka M, Hökfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998;95:15769-15774.
25. Rajanikant GK, Zemke D, Senut MC, Frenkel MB, Chen AF, Gupta R, et al. Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke 2007;38:3023-3031.
26. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007;321:892-901.
27. Tambuyzer BR, Ponsaerts P, Nouwen EJ. Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 2009;85:352-370.
28. Griffin WS, Mrak RE. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 2002;72:233-238.
29. Yang B, Meng Z, Dong J, Yan L, Zou L, Tang Z, et al. Metabolic profile of 1,5-dicaffeoylquinic acid in rats, an in vivo and in vitro study. Drug Metab Dispos 2005;33:930-936.
30. Chow SA, Cordeiro M, Atienza J, Robinson WE. Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids. J Virol 1999;73:3309-3316.
31. Robinson WE, Jr Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reinecke MG, et al. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol Pharmacol 1996;50:846-855.
32. dos Santos, Gobbo-Neto L, Albarella L, de Souza GE, Lopes NP. Analgesic activity of di-Caffeoylquinic acids from roots of Lychnophora ericoides (Arnica da serra). J Ethnopharmacol 2005;96:545-549.
33. Kimura Y, Okuda H, Okuda T, Hatano T, Arichi SJ. Studies on the activities of tannins and related compounds, X. Effects of Caffeetannins and related compounds on arachidonate metabolism in human polymorphonuclear leukocytes. Nat Prod 1987;50:392-399.
34. Wu Y, Zhou C, Song L, Li X, Shi S, Mo J, et al. Effect of total phenolics from Laggera alata on acute and chronic inflammation models. J Ethnopharmacol 2006;108:243-250.
35. Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 2003;10.1096/fj.03-0057fje.
36. Park JS, Woo MS, Kim DH, Hyun JW, Kim WK, Lee JC, et al. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide- stimulated microglial cells. J Pharmacol Exp Ther 2007;320:1237-1245.